查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2104566

膽紅素檢測市場：依產品、技術、應用、患者、最終用途、國家及地區分類－全球產業分析、市場規模、市場佔有率及2026年至2033年預測

Bilirubin Testing Market, By Product, By Technology, By Application, By Patient, By End Use, By Country, and By Region -Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
出版日期: | 出版商: AnalystView Market Insights | 英文 327 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2025 年，膽紅素檢測市場價值將達到 22.308 億美元，從 2026 年到 2033 年將以 4.2% 的複合年成長率成長。

膽紅素檢測是一種臨床化學檢查，用於測量血液中橙黃色物質膽紅素的濃度，是評估黃疸、肝功能損傷和紅血球分解率的重要指標。膽紅素檢測中，將靜脈檢體檢體與重氮試劑混合，然後進行比色分析。此方法可將膽紅素分離為結合膽紅素和非結合膽紅素，並使用分析儀測量它們的濃度。因此，膽紅素檢測能夠實現準確診斷、有效監測疾病並及時做出臨床決策。

膽紅素檢測市場 - 市場動態

對早期診斷日益成長的需求正在推動市場需求。

人們對新生兒黃疸的認知不斷提高、肝病高發以及醫院和診所對快速可靠診斷檢測的需求日益成長，正在推動膽紅素檢測市場的發展。例如，根據經合組織（OECD）的數據，到2026年，需要建立相應的系統，以確保癌症能夠儘早診斷，從而滿足早期癌症檢測的需求。乳癌的早期診斷率為56%，子宮頸癌為62%，而大腸癌的早期診斷率僅22%。顯然，患者需要更有效的篩檢程序、快速且準確的診斷檢測以及早期治療才能戰勝疾病。因此，對疾病早期檢測的日益重視很可能推動全球膽紅素檢測市場的成長。

膽紅素檢測市場－市場區隔分析：

全球膽紅素檢測市場按產品、技術、應用、患者、最終用途和地區進行細分。

在所列產品中，膽紅素試劑組和檢測耗材佔據了相當大的市場。這是因為它們不僅在常規檢測中頻繁使用，而且是這些檢測中測量膽紅素濃度的必備產品。 2025年7月，Nova Biomedical推出了最新版本的“BR2膽紅素檢測套組”，該試劑盒採用預先包裝的檢測耗材，可快速測量總膽紅素和直接膽紅素濃度。因此，膽紅素試劑組的使用仍得到廣泛支持。

膽紅素檢測市場—區域分析

由於北美擁有高度發展的醫療保健基礎設施、新生兒黃疸早期篩檢以及肝病病例不斷增加，因此在膽紅素檢測市場佔據了相當大的佔有率。例如，根據美國疾病管制與預防中心（CDC）的數據，到2026年，慢性肝病將成為美國的主要健康問題。美國約有450萬成年人患有肝病，18歲以上人口的盛行率為1.8%。在美國，已有52274人死於慢性肝病和肝硬化，死亡率為每10萬人15.4人。這使得慢性肝病和肝硬化成為美國第九大死因。因此，肝病發生率的上升正在推動先進膽紅素檢測套組的應用。

在醫院檢查室現代化、臨床化學檢測中自動化系統的應用以及與疾病預防和治療相關的各項醫療保健計劃的推動下，法國的膽紅素檢測市場持續成長。例如，根據歐洲醫療技術協會（MedTech Europe）預測，到2025年，法國將成為歐洲最大的體外診斷（IVD）市場之一，市場規模約為24億美元。報告指出，醫院檢查室現代化的趨勢主要得益於自動化診斷系統的廣泛應用、分子診斷技術在臨床檢查室的引入以及工作流程的數位化，從而加速了法國醫療保健系統的診斷進程。此次投資旨在加速法國各地最新膽紅素檢測解決方案的普及應用。

目錄

第1章：膽紅素檢測市場概覽

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章：膽紅素檢測市場的主要趨勢

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 未來市場趨勢

第4章：膽紅素檢測產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長前景展望圖
  • 管理體制分析

第5章：膽紅素檢測市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：膽紅素檢測市場現狀

  • 膽紅素檢測市佔率分析，2025 年
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章 膽紅素檢測市場：依產品分類

  • 概述
    • 基於細分市場的市佔率分析：按產品
    • 膽紅素測量設備（經皮和血液測量類型）
    • 膽紅素試劑組和檢測耗材
    • 測試盒和試紙
    • 校準試劑和品管試劑
    • 其他

第8章：膽紅素檢測市場：依技術分類

  • 概述
    • 基於細分市場的市場佔有率分析：按技術分類
    • 即時檢測
    • 檢查室測試
    • 其他

第9章：膽紅素檢測市場：依應用領域分類

  • 概述
    • 基於細分市場的市場佔有率分析：按應用領域
    • 定期健康檢查及術前檢查
    • 溶血性疾病的評估
    • 肝功能檢查（LFT）
    • 新生兒黃疸的篩檢和監測
    • 其他

第10章：膽紅素檢測市場：依患者分類

  • 概述
    • 基於細分市場的市場佔有率分析：按患者分類
    • 成人
    • 兒童患者
    • 新生

第11章 膽紅素檢測市場：依最終用途分類

  • 概述
    • 按最終用途分類的市佔率分析。
    • 產科和新生兒科
    • 診斷檢查室
    • 醫院及新生兒加護病房
    • 其他

第12章 膽紅素檢測市場：依地區分類

  • 介紹
  • 北美洲
    • 概述
    • 主要製造商：北美
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 主要製造商：歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 丹麥
    • 其他歐洲國家
  • 亞太地區
    • 概述
    • 主要製造商：亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 台灣
    • 越南
    • 其他亞太國家
  • 拉丁美洲
    • 概述
    • 主要製造商：拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他拉丁美洲國家
  • 中東和非洲
    • 概述
    • 主要生產商：中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 伊朗
    • 卡達
    • 其他中東和非洲國家

第13章：主要供應商分析：膽紅素檢測產業

  • 競爭基準
    • 競爭對手儀錶板
    • 競爭定位
  • 公司簡介
    • Abbott Laboratories
    • F. Hoffmann-La Roche Ltd.
    • Siemens Healthineers AG
    • Thermo Fisher Scientific Inc.
    • Bio-Rad Laboratories, Inc.
    • bioMerieux SA
    • DiaSys Diagnostic Systems GmbH
    • HORIBA Ltd.
    • ELITechGroup SAS
    • QuidelOrtho Corporation
    • Sysmex Corporation
    • Mindray Bio-Medical Electronics Co., Ltd.
    • DiaSorin SpA
    • Erba Mannheim
    • Ortho Clinical Diagnostics, Inc.
    • Others

第14章：AnalystView 的全景視圖

簡介目錄
Product Code: ANV7028

Bilirubin Testing market size was valued at US$ 2,230.8 Million in 2025, expanding at a CAGR of 4.2% from 2026 to 2033.

A bilirubin laboratory test is a clinical chemistry test that helps measure levels of the orange-yellow bilirubin substance in the blood and provides a vital marker for jaundice, poor functioning of the liver, and the rate of breakdown of the red blood cells. The bilirubin test relies on the use of a venous blood sample mixed with the diazo reagent to conduct colorimetric analysis of the bilirubin. This is because the bilirubin is separated into conjugated bilirubin and unconjugated bilirubin, and their concentrations are measured using an analyzer. Thus, bilirubin testing enables accurate diagnosis, effective disease monitoring, and timely clinical decision-making.

Bilirubin Testing Market- Market Dynamics

Growing demand for early diagnosis to propel market demand

Growing demand for early diagnosis is driving the Bilirubin Testing market because awareness about neonatal jaundice is on the rise, incidences of liver diseases are high, and there is an increasing need for fast and reliable diagnostic tests in the hospitals and clinics. For instance, in 2026, according to the OECD, there is a need to have access to the cancer diagnosis at the earliest in order to satisfy the requirement for the early detection of cancer. The rate of early diagnosis of breast cancer was 56% and that of cervical cancer was 62%, while that of colorectal cancer was 22%. Clearly, there is a need for more effective screening procedures, faster and accurate diagnostic testing, and early treatment to ensure that the patients survive their diseases. Therefore, there will be an increased focus on early disease detection and hence drive the growth of bilirubin testing globally.

Bilirubin Testing Market- Segmentation Analysis:

The Global Bilirubin Testing market is segmented on the basis of Product, Technology, Application, Patient, End Use, and Region.

Among the given products, bilirubin reagent kits and assay consumables account for a prominent market share in the products that are listed, as these products are frequently utilized for the tests that are conducted regularly along with being vital for the determination of the bilirubin level in the test. In July 2025, Nova Biomedical launched its latest version of the BR2 Bilirubin Test Kit that has pre-packed assay consumables that aid in quick testing of total and direct bilirubin levels. Thus, use of bilirubin reagent kits is still widely supported.

Bilirubin Testing Market- Geographical Insights

North America holds notable share in the Bilirubin Testing market because of the presence of highly developed health care infrastructure, early screening of jaundice in newborns, and an increased number of cases of liver diseases. For instance, in 2026, according to the U.S. Centers for Disease Control and Prevention (CDC), chronic liver disease is an important health problem in the country; there are about 4.5 million US adults with liver disease, with 1.8% of the US population aged 18 years and above suffering from liver disease. There are 52,274 people in America dying due to chronic liver disease and cirrhosis, with a death rate of 15.4 deaths per 100,000 people; that makes chronic liver disease and cirrhosis the ninth leading cause of mortality in the United States. In this regard, the growing incidences of liver diseases have driven the adoption of advanced bilirubin testing kits.

France's industry of bilirubin testing is growing due to the modernization of hospitals' laboratories, the use of automated systems for clinical chemistry, and various healthcare programs related to prevention and treatment of diseases. For instance, in 2025, according to MedTech Europe, France will have one of the largest IVD markets in Europe and will be worth about (USD 2,400 million). The report indicates that the trend of modernization of hospital laboratories is caused by the extensive use of automated diagnostic systems, as well as using molecular diagnostics and digitalization of the workflow in clinical laboratories in order to accelerate the process of diagnosing in the health care system of the country. This investment is to speed up adoption of the latest solutions in bilirubin testing throughout France.

Bilirubin Testing Market- Competitive Landscape:

The Bilirubin Testing market comprises major players such as Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Thermo Fisher Scientific Inc., and Bio-Rad Laboratories, Inc. These companies have increased their market share through innovations in diagnostics and automation in laboratories and testing systems, as well as through their growing geographical presence and portfolio. In November 2025, Abbott Laboratories acquired Exact Sciences in order to integrate the diagnostics of Abbott, which include laboratory testing and precision diagnostics. The acquisition will help Abbott to integrate Exact Sciences in the laboratory test segment, which will add advanced clinical diagnostic capabilities to Abbott's capabilities. These strategic initiatives enhance diagnostic capabilities, accelerate innovation, and strengthen competitive positioning in the bilirubin testing market.

Recent Developments:

In March 2026, Siemens Healthineers AG (Frankfurt, Germany) launched the Atellica IM pTau217 and BDTau immunoassays as tests for research purposes. These are part of Siemens' Atellica IM portfolio that is now being expanded with next-generation biomarker assays, improving their integrated solution for clinical chemistry and immunoassay testing capabilities.

In January 2025, Thermo Fisher Scientific Inc. acquired the Purification & Filtration Division of Solventum under an acquisition that was valued at about $4.1 billion. The acquisition is expected to expand Thermo Fisher's product range which includes the analytical and clinical laboratory products for conducting diagnostics tests.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BILIRUBIN TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • DiaSys Diagnostic Systems GmbH
  • HORIBA Ltd.
  • ELITechGroup SAS
  • QuidelOrtho Corporation
  • Sysmex Corporation
  • Mindray Bio-Medical Electronics Co., Ltd.
  • DiaSorin S.p.A.
  • Erba Mannheim
  • Ortho Clinical Diagnostics, Inc.
  • Others

GLOBAL BILIRUBIN TESTING MARKET, BY PRODUCT- MARKET ANALYSIS, 2020 - 2033

  • Bilirubinometers (Transcutaneous & Blood-Based)
  • Bilirubin Reagent Kits & Assay Consumables
  • Test Cartridges & Strips
  • Calibrators & Quality Controls
  • Others

GLOBAL BILIRUBIN TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033

  • POC Testing
  • Laboratory-Based Testing

GLOBAL BILIRUBIN TESTING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

  • Routine & Pre-operative Health Screening
  • Hemolytic Disorders Assessment
  • Liver Function Testing (LFT)
  • Neonatal Jaundice Screening and Monitoring

GLOBAL BILIRUBIN TESTING MARKET, BY PATIENT- MARKET ANALYSIS, 2020 - 2033

  • Adults
  • Pediatric Patients
  • Neonates

GLOBAL BILIRUBIN TESTING MARKET, BY END USE- MARKET ANALYSIS, 2020 - 2033

  • Maternity and Neonatal Clinics
  • Diagnostic Laboratories
  • Hospitals & NICUs
  • Others

GLOBAL BILIRUBIN TESTING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

Table of Contents

1. Bilirubin Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Bilirubin Testing Market Snippet by Product
    • 2.1.2. Bilirubin Testing Market Snippet by Technology
    • 2.1.3. Bilirubin Testing Market Snippet by Application
    • 2.1.4. Bilirubin Testing Market Snippet by Patient
    • 2.1.5. Bilirubin Testing Market Snippet by End Use
    • 2.1.6. Bilirubin Testing Market Snippet by Country
    • 2.1.7. Bilirubin Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Bilirubin Testing Key Market Trends

  • 3.1. Bilirubin Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Bilirubin Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Bilirubin Testing Market Opportunities
  • 3.4. Bilirubin Testing Market Future Trends

4. Bilirubin Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Bilirubin Testing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Bilirubin Testing Market Landscape

  • 6.1. Bilirubin Testing Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Bilirubin Testing Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2025 & 2033 (%)
    • 7.1.2. Bilirubinometers (Transcutaneous & Blood-Based)
    • 7.1.3. Bilirubin Reagent Kits & Assay Consumables
    • 7.1.4. Test Cartridges & Strips
    • 7.1.5. Calibrators & Quality Controls
    • 7.1.6. Others

8. Bilirubin Testing Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2025 & 2033 (%)
    • 8.1.2. POC Testing
    • 8.1.3. Laboratory-Based Testing
    • 8.1.4. Others

9. Bilirubin Testing Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 9.1.2. Routine & Pre-operative Health Screening
    • 9.1.3. Hemolytic Disorders Assessment
    • 9.1.4. Liver Function Testing (LFT)
    • 9.1.5. Neonatal Jaundice Screening and Monitoring
    • 9.1.6. Others

10. Bilirubin Testing Market - By Patient

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Patient, 2025 & 2033 (%)
    • 10.1.2. Adults
    • 10.1.3. Pediatric Patients
    • 10.1.4. Neonates

11. Bilirubin Testing Market - By End Use

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End Use, 2025 & 2033 (%)
    • 11.1.2. Maternity and Neonatal Clinics
    • 11.1.3. Diagnostic Laboratories
    • 11.1.4. Hospitals & NICUs
    • 11.1.5. Others

12. Bilirubin Testing Market - By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Bilirubin Testing Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Bilirubin Testing Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 12.3.18. Denmark
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.18.3. Denmark Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.3.18.4. Denmark Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.18.5. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.18.6. Denmark Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
      • 12.3.18.7. Denmark Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 12.3.19. Rest of Europe
      • 12.3.19.1. Overview
      • 12.3.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.19.3. Rest of the Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.3.19.4. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.19.5. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.19.6. Rest of the Europe Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
      • 12.3.19.7. Rest of the Europe Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Bilirubin Testing Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 12.4.17. Taiwan
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.17.3. Taiwan Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.4.17.4. Taiwan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.17.5. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.17.6. Taiwan Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
      • 12.4.17.7. Taiwan Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 12.4.18. Vietnam
      • 12.4.18.1. Overview
      • 12.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.18.3. Vietnam Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.4.18.4. Vietnam Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.18.5. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.18.6. Vietnam Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
      • 12.4.18.7. Vietnam Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 12.4.19. Rest of APAC
      • 12.4.19.1. Overview
      • 12.4.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.19.3. Rest of APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.4.19.4. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.19.5. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.19.6. Rest of APAC Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
      • 12.4.19.7. Rest of APAC Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. Bilirubin Testing Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Bilirubin Testing Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 12.6.15. Iran
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.15.3. Iran Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.6.15.4. Iran Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.15.5. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.15.6. Iran Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
      • 12.6.15.7. Iran Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 12.6.16. Qatar
      • 12.6.16.1. Overview
      • 12.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.16.3. Qatar Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.6.16.4. Qatar Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.16.5. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.16.6. Qatar Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
      • 12.6.16.7. Qatar Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)
    • 12.6.17. Rest of MEA
      • 12.6.17.1. Overview
      • 12.6.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.17.3. Rest of MEA Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.6.17.4. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.17.5. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.17.6. Rest of MEA Market Size and Forecast, By Patient, 2020 - 2033 (US$ Million)
      • 12.6.17.7. Rest of MEA Market Size and Forecast, By End Use, 2020 - 2033 (US$ Million)

13. Key Vendor Analysis- Bilirubin Testing Industry

  • 13.1. Competitive Benchmarking
    • 13.1.1. Competitive Dashboard
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. Abbott Laboratories
    • 13.2.2. F. Hoffmann-La Roche Ltd.
    • 13.2.3. Siemens Healthineers AG
    • 13.2.4. Thermo Fisher Scientific Inc.
    • 13.2.5. Bio-Rad Laboratories, Inc.
    • 13.2.6. bioMerieux SA
    • 13.2.7. DiaSys Diagnostic Systems GmbH
    • 13.2.8. HORIBA Ltd.
    • 13.2.9. ELITechGroup SAS
    • 13.2.10. QuidelOrtho Corporation
    • 13.2.11. Sysmex Corporation
    • 13.2.12. Mindray Bio-Medical Electronics Co., Ltd.
    • 13.2.13. DiaSorin S.p.A.
    • 13.2.14. Erba Mannheim
    • 13.2.15. Ortho Clinical Diagnostics, Inc.
    • 13.2.16. Others

14. 360 Degree AnalystView

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us